Literature DB >> 3902871

An update on human interleukin-1: from molecular biology to clinical relevance.

C A Dinarello.   

Abstract

Interleukin-1 (IL-1) represents a family of polypeptides with a wide range of biological activities. At least two dissimilar gene products have been cloned; there are probably more. The human IL-1 family plays an important role in the pathogenesis of many diseases and functions as a key mediator of the host response to various infectious, inflammatory, and immunologic challenges. Recombinant mouse (pI 5) and recombinant human (pI 7) IL-1's are being used to confirm the multiple biological properties of IL-1's but considerable investigation is required before the specific activities (biological units per milligram of protein) are established for each human IL-1 form. Some IL-1 biological activities such as the induction of hepatic acute-phase protein synthesis have been demonstrated in invertebrates predating the evolution of lymphocytes. IL-1 is highly inflammatory and increases the concentration of metabolites of arachidonic acid, most notably prostaglandin E2, in brain, muscle, chondrocytes, and synovial fibroblasts. The synthesis of leukotrienes also is involved in the mechanism of its action on certain tissues. The cloning and expression of human IL-1 genes will expand our understanding of IL-1 in various diseases through improved detection systems and the use of cDNA probes; the development of IL-1 antagonists, as well as the use of IL-1 as an immunomodulator, is presently being considered.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3902871     DOI: 10.1007/bf00918247

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  54 in total

1.  Fever: the old and the new.

Authors:  E Atkins
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

2.  Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis.

Authors:  A Fontana; H Hengartner; E Weber; K Fehr; P J Grob; G Cohen
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

Review 3.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

4.  Interleukin 1 activity in normal human urine.

Authors:  E S Kimball; S F Pickeral; J J Oppenheim; J L Rossio
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

5.  In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.

Authors:  M T Lotze; L W Frana; S O Sharrow; R J Robb; S A Rosenberg
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

6.  Differential effects of human interleukin-1 on growth of human fibroblasts and vascular smooth muscle cells.

Authors:  P Libby; D J Wyler; M W Janicka; C A Dinarello
Journal:  Arteriosclerosis       Date:  1985 Mar-Apr

7.  Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1.

Authors:  J Van Damme; M De Ley; G Opdenakker; A Billiau; P De Somer; J Van Beeumen
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

Review 8.  Molecular basis of fever in humans.

Authors:  C A Dinarello; S M Wolff
Journal:  Am J Med       Date:  1982-05       Impact factor: 4.965

9.  Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s).

Authors:  I Gery; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

10.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; R S Cotran; M A Gimbrone
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  63 in total

1.  Ultrastructural localisation of nitric oxide synthase, endothelin and binding sites of lectin (from Bandeirea simplicifolia) in the rat carotid artery after balloon catheter injury.

Authors:  A Loesch; P Milner; S C Anglin; R Crowe; S Miah; J R McEwan; G Burnstock
Journal:  J Anat       Date:  1997-01       Impact factor: 2.610

Review 2.  Regulatory mechanisms of antitumor T cell responses in the tumor-bearing state.

Authors:  H Fujiwara; T Hamaoka
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

3.  Glomerular cells and macrophages in the progression of experimental focal and segmental glomerulosclerosis.

Authors:  K Matsumoto; R C Atkins
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

Review 4.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

5.  Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha.

Authors:  B Meier; H H Radeke; S Selle; M Younes; H Sies; K Resch; G G Habermehl
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

6.  Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3-Aza-lipid X.

Authors:  R L Danner; K A Joiner; J E Parrillo
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

7.  Expression of interleukin-1 in Reed-Sternberg cells and neoplastic cells from true histiocytic malignancies.

Authors:  S M Hsu; X Zhao
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

8.  Antidiabetic effects of interleukin 1.

Authors:  A del Rey; H Besedovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Recombinant human interleukin-1 alpha and recombinant human interleukin-1 beta stimulate cartilage matrix degradation and inhibit glycosaminoglycan synthesis.

Authors:  R J Smith; N A Rohloff; L M Sam; J M Justen; M R Deibel; J C Cornette
Journal:  Inflammation       Date:  1989-08       Impact factor: 4.092

10.  Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells.

Authors:  P Libby; J M Ordovas; K R Auger; A H Robbins; L K Birinyi; C A Dinarello
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.